NYSE American - Delayed Quote USD

Milestone Scientific Inc. (MLSS)

0.3020 +0.0029 (+0.97%)

At close: November 6 at 4:00:00 PM EST

Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures

GlobeNewswire 10d ago

MLSS
+1.54%
Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

GlobeNewswire 1mo ago

MLSS
+1.54%
Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

GlobeNewswire 1mo ago

MLSS
+1.54%
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

GlobeNewswire 2mo ago

MLSS
+1.54%
Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ...

GuruFocus.com 2mo ago

MLSS
+1.54%
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

GlobeNewswire 3mo ago

MLSS
+1.54%
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

GlobeNewswire 3mo ago

MLSS
+1.54%
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

GlobeNewswire 3mo ago

MLSS
+1.54%
Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

GlobeNewswire 4mo ago

MLSS
+1.54%
Milestone Scientific Strengthens Board to Support Next Phase of Growth

GlobeNewswire 4mo ago

MLSS
+1.54%
Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

GlobeNewswire 5mo ago

MLSS
+1.54%
Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...

GuruFocus.com 5mo ago

MLSS
+1.54%

U.S. markets closed

Milestone Scientific Inc. (MLSS)

Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures

Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business

Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor

Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors

Milestone Scientific Inc (MLSS) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on ...

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026

Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY

Milestone Scientific Strengthens Board to Support Next Phase of Growth

Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures

Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...